Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.36 Analyst target: $1.38 Upside: 286.34%
Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States. The company is headquartered in Princeton, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.